New prognostic score for patients with mRCC: the Immuno-IMDC
BiomarkersImmunological classificationmeasurementPrognostic factorsRenal cell carcinoma (RCC)
Patent filed for less than 18 months, still in the period of secrecy
Register to get more information and contact the inventors.
REGISTRATION